Stockreport

Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs [Yahoo! Finance]

Ginkgo Bioworks Holdings, Inc.  (DNA) 
PDF biosecurity, announced the acquisition of Modulus Therapeutics' cell therapy platform assets, including their chimeric antigen receptor (CAR) and switch receptor librari [Read more]